Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20180624040228N3Phase 3Completed
Phase 3, randomised, double-blind trial of phenylephrine and lidocaine in epistaxis (2 arms), sponsored by Shahid Sadoughi University of Medical Sciences. Primary endpoints: Nasal bleeding control at 5 minutes, Nasal bleeding control at 10 minutes and 1 more. Started Apr 2020; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20180624040228N3.